Hyperion Therapeutics to Present at Needham's 12th Annual Healthcare
SOUTH SAN FRANCISCO, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- Hyperion
Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to
present at Needham's 12^th Annual Healthcare Conference on Tuesday, April 30
at 9:20 a.m. ET.
Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company
overview. To access the live webcast and subsequent archived recording, please
visit Hyperion's website at http://investors.hyperiontx.com/events.cfm.
About Hyperion Therapeutics
Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company
committed to developing and delivering life-changing treatments for orphan
diseases and hepatology.
CONTACT: Shari Annes, Investor Relations
Kristie Kuhl, Media Relations
Press spacebar to pause and continue. Press esc to stop.